Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mibc”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06879145
What this trial is testing

Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)

Who this might be right for
Muscular Invasive Bladder Cancer (MIBC)
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 840
Not applicableUnknownNCT05097404
What this trial is testing

Clinical Utility of VI-RADS in Diagnosis of MIBC

Who this might be right for
Radical CystectomyMuscle-Invasive Bladder CarcinomaMultiparametric MRI+1 more
Samsung Medical Center 73
Testing effectiveness (Phase 2)Active Not RecruitingNCT03697850
What this trial is testing

Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy

Who this might be right for
Bladder Cancer
UNICANCER 79
Testing effectiveness (Phase 2)Ended earlyNCT05041101
What this trial is testing

Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer

Who this might be right for
Breast Inflammatory CarcinomaRecurrent Breast Inflammatory CarcinomaStage IV Breast Inflammatory Carcinoma
M.D. Anderson Cancer Center 6
Not applicableUnknownNCT05767528
What this trial is testing

Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Chinese PLA General Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT05879653
What this trial is testing

Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD)

Who this might be right for
Bladder Cancer
Kyoto University Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07624201
What this trial is testing

Trastuzumab Rezetecan and Adebrelimab as Neoadjuvant Therapy for HER2-Positive Muscle-Invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Cancer (MIBC)
Harbin Medical University 58
Testing effectiveness (Phase 2)UnknownNCT04543110
What this trial is testing

Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC

Who this might be right for
Bladder Cancer
Ottawa Hospital Research Institute 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT04630730
What this trial is testing

Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC

Who this might be right for
Bladder Cancer
Swiss Cancer Institute 46
Early research (Phase 1)Active Not RecruitingNCT02546661
What this trial is testing

Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Cancer
AstraZeneca 117
Large-scale testing (Phase 3)Study completedNCT03924856
What this trial is testing

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

Who this might be right for
Bladder Cancer
Merck Sharp & Dohme LLC 907
Testing effectiveness (Phase 2)Looking for participantsNCT04724928
What this trial is testing

Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
University Hospital, Ghent 156
Not applicableUnknownNCT05236218
What this trial is testing

To Better Understand the Most Important Factors for Patients When They Decide on the Type of Treatment They Receive for Muscle Invasive Bladder Cancer (MIBC).

Who this might be right for
Muscle Invasive Bladder CancerSurgerySexual Wellbeing+2 more
King's College London 60
Testing effectiveness (Phase 2)UnknownNCT04813107
What this trial is testing

Evaluate the Safety and Efficacy of Oral APL-1202 in Combination With Tislelizumab Compared to Tislelizumab Alone as Neoadjuvant Therapy in Patients With Muscle Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Cancer
Jiangsu Yahong Meditech Co., Ltd aka Asieris 79
Not applicableLooking for participantsNCT07756437
What this trial is testing

Validation of a Circulating Tumor DNA Blood Test in Muscle-Invasive Bladder and Upper Tract Urothelial Cancer

Who this might be right for
Muscle-Invasive Bladder Cancer (MIBC)Upper Tract Urothelial CarcinomaUrothelial Carcinoma (UC)
AZ Sint-Lucas Gent 70
Testing effectiveness (Phase 2)Looking for participantsNCT05072600
What this trial is testing

Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer

Who this might be right for
Bladder CancerBladder NeoplasmsBladder Tumors+2 more
Peking University First Hospital 54
Large-scale testing (Phase 3)Active Not RecruitingNCT04241185
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)

Who this might be right for
Urinary Bladder Neoplasms
Merck Sharp & Dohme LLC 520